OJSC Pharmsynthez reported earnings results for the six months ended June 30, 2016. For the period, the company's net profit to Russian Accounting Standards (RAS) in the amount of RUB 147.296 million against losses of RUB 84.033 million a year earlier. Revenue fell 45.3% to RUB 115.974 million. Operating losses fell 77% to RUB 8.716 million. Pretax profit amounted to RUB 133.06 million against losses in the amount of RUB 91.777 million a year earlier.